Cannon Michael J, Stowell Jennifer D, Clark Rebekah, Dollard Philip R, Johnson Delaney, Mask Karen, Stover Cynthia, Wu Karen, Amin Minal, Hendley Will, Guo Jing, Schmid D Scott, Dollard Sheila C
BMC Infect Dis. 2014 Nov 13;14:569. doi: 10.1186/s12879-014-0569-1.
To better understand potential transmission risks from contact with the body fluids of children, we monitored the presence and amount of CMV shedding over time in healthy CMV-seropositive children.
Through screening we identified 36 children from the Atlanta, Georgia area who were CMV-seropositive, including 23 who were shedding CMV at the time of screening. Each child received 12 weekly in-home visits at which field workers collected saliva and urine. During the final two weeks, parents also collected saliva and urine daily.
Prevalence of shedding was highly correlated with initial shedding status: children shedding at the screening visit had CMV DNA in 84% of follow-up saliva specimens (455/543) and 28% of follow-up urine specimens (151/539); those not shedding at the screening visit had CMV DNA in 16% of follow-up saliva specimens (47/303) and 5% of follow-up urine specimens (16/305). Among positive specimens we found median viral loads of 82,900 copies/mL in saliva and 34,730 copies/mL in urine (P=0.01), while the viral load for the 75th percentile was nearly 1.5 million copies/mL for saliva compared to 86,800 copies/mL for urine. Younger age was significantly associated with higher viral loads, especially for saliva (P<0.001). Shedding prevalence and viral loads were relatively stable over time. All children who were shedding at the screening visit were still shedding at least some days during weeks 11 and 12, and median and mean viral loads did not change substantially over time.
Healthy CMV-seropositive children can shed CMV for months at high, relatively stable levels. These data suggest that behavioral prevention messages need to address transmission via both saliva and urine, but also need to be informed by the potentially higher risks posed by saliva and by exposures to younger children.
为了更好地了解接触儿童体液可能带来的传播风险,我们对健康的巨细胞病毒血清阳性儿童体内巨细胞病毒脱落的存在情况及数量随时间的变化进行了监测。
通过筛查,我们从佐治亚州亚特兰大地区确定了36名巨细胞病毒血清阳性儿童,其中23名在筛查时正在排出巨细胞病毒。每个孩子每周接受12次家访,现场工作人员在访视时收集唾液和尿液。在最后两周,家长也每天收集唾液和尿液。
病毒脱落的患病率与初始脱落状态高度相关:在筛查访视时正在排出病毒的儿童,其后续唾液样本中有84%(455/543)检测到巨细胞病毒DNA,后续尿液样本中有28%(151/539)检测到;在筛查访视时未排出病毒的儿童,其后续唾液样本中有16%(47/303)检测到巨细胞病毒DNA,后续尿液样本中有5%(16/305)检测到。在阳性样本中,我们发现唾液中的病毒载量中位数为82,900拷贝/毫升,尿液中的病毒载量中位数为34,730拷贝/毫升(P = 0.01),而第75百分位数的病毒载量,唾液中近150万拷贝/毫升,尿液中为86,800拷贝/毫升。年龄较小与较高的病毒载量显著相关,尤其是唾液中的病毒载量(P < 0.001)。病毒脱落患病率和病毒载量随时间相对稳定。所有在筛查访视时正在排出病毒的儿童在第11周和第12周期间至少有几天仍在排出病毒,且病毒载量中位数和平均值随时间没有实质性变化。
健康的巨细胞病毒血清阳性儿童可以在数月内以较高且相对稳定的水平排出巨细胞病毒。这些数据表明,行为预防信息需要同时涉及通过唾液和尿液传播的问题,而且还需要考虑到唾液以及接触年幼儿童可能带来的更高风险。